Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
26.68
+0.41 (1.56%)
Oct 23, 2026, 3:00 PM CST
SHA:603351 Market Cap
SHA:603351 has a market cap or net worth of 3.61 billion as of October 23, 2026. It is the 13,946th most valuable company in the world and the 3,704th biggest in China. Its market cap has decreased by 2.49% in one year.
Market Cap
3.61B
Enterprise Value
3.82B
Revenue
1.40B
Global Rank
Country Rank
#3,704 China
PE Ratio
23.41
ChartMarket Cap Chart
Since January 30, 2019, SHA:603351's market cap has increased from 3.41B to 3.61B, an increase of 6.03%. That is a compound annual growth rate of 0.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 3.61B | 2.54% |
| Dec 31, 2025 | 3.52B | 5.94% |
| Dec 31, 2024 | 3.33B | -6.86% |
| Dec 29, 2023 | 3.57B | 21.88% |
| Dec 30, 2022 | 2.93B | -42.75% |
| Dec 31, 2021 | 5.12B | 71.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ChengDa Pharmaceuticals | 4.02B |
| Jinling Pharmaceutical Company | 3.92B |
| Sinotherapeutics | 3.92B |
| Hainan Shuangcheng Pharmaceuticals | 3.85B |
| Newland Pharmaceutical | 3.81B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 3.78B |
| Beijing Science Sun Pharmaceutical | 3.77B |
| Tibet Weixinkang Medicine | 3.75B |